Van professionele vertalers, bedrijven, webpagina's en gratis beschikbare vertaalbronnen.
deboronated-bortezomib metabolites are inactive as 26s proteasome inhibitors.
deboronuoti bortezomibo metabolitai nepasizymi 26s proteasom slopinanciu poveikiu.
inhibition of the proteasome results in cell cycle arrest and apoptosis.
dl proteasomos slopinimo sustoja lstels ciklas ir vyksta apoptoz.
the active substance in velcade, bortezomib, is a proteasome inhibitor.
veiklioji velcade medziaga bortezomibas yra proteasomos inhibitorius.
cancer cells are more sensitive than normal cells to the effects of proteasome inhibitors like bortezomib.
vėžinės ląstelės jautresnės nei normalios ląstelės proteosomos inhibitorių, tokių kaip bortezomibas, poveikiui.
such influence is supported by limited clinical data and preclinical studies showing egfr degradation through the proteasome.
tokį poveikį pagrindžia nedaug klinikinių ir ikiklinikinių tyrimų metu gautų duomenų, rodančių egfr degradaciją proteosomose.
amyloidosisthe impact of proteasome inhibition by bortezomib on disorders associated with protein accumulation such as amyloidosis is unknown.
amiloidoz bortezomibo slopinancio poveikio proteasomai taka su baltym kaupimu susijusiems sutrikimams (tokiems, kaip amiloidoz) nra zinoma.
it blocks the proteasome, which is a system within the cells that breaks down proteins when they are no longer needed.
jis slopina proteasom, kuri sudaro lstelse sistem, suardanci nebereikalingus baltymus.
inhibition of the 26s proteasome prevents this targeted proteolysis and affects multiple signalling cascades within the cell, ultimately resulting in cancer cell death.
10 26s proteasomos slopinimas apsaugo nuo sios kryptingos proteolizs ir veikia daugyb signalini kaskad lstels viduje, kas galiausiai sukelia vzini lsteli zt.
experiments have demonstrated that bortezomib is cytotoxic to a variety of cancer cell types and that cancer cells are more sensitive to the proapoptotic effects of proteasome inhibition than normal cells.
eksperimentais nustatyta, kad bortezomibas sukelia citotoksin poveik vairi tip vzinms lstelms, ir kad vzins lstels bna daug jautresns proapoptoziniam proteasomos inhibitori poveikiui negu normalios lstels.
dexamethasone apoptotic activity is enhanced by the combination with thalidomide or its analogues and with proteasome inhibitor (e.g. bortezomib).
deksametazono apoptozinis poveikis stiprėja, kai jis vartojamas kartu su talidomidu arba jo analogais ir proteazės inhibitoriumi (pvz., bortezomibu).